PL409095A1 - A composition for the psoriasis and eczema therapy - Google Patents

A composition for the psoriasis and eczema therapy

Info

Publication number
PL409095A1
PL409095A1 PL409095A PL40909514A PL409095A1 PL 409095 A1 PL409095 A1 PL 409095A1 PL 409095 A PL409095 A PL 409095A PL 40909514 A PL40909514 A PL 40909514A PL 409095 A1 PL409095 A1 PL 409095A1
Authority
PL
Poland
Prior art keywords
volume
amount
psoriasis
composition
eczema
Prior art date
Application number
PL409095A
Other languages
Polish (pl)
Other versions
PL225026B1 (en
Inventor
Renata Firgon
Original Assignee
Renata Firgon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renata Firgon filed Critical Renata Firgon
Priority to PL409095A priority Critical patent/PL225026B1/en
Publication of PL409095A1 publication Critical patent/PL409095A1/en
Publication of PL225026B1 publication Critical patent/PL225026B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Kompozycja do terapii łuszczycy oraz egzemy, w postaci maści albo kremu, zawiera rybi kolagen w postaci żelu w ilości 5 - 80% objętościowych, olej jojoba w ilości 1 - 75% objętościowych, alkohol cetylowy w ilości 0,5 - 8% objętościowych, wazelinę w ilości 5 - 25% objętościowych oraz olejek eteryczny w ilości 0 - 5% objętościowych, korzystnie olejek pomarańczowy.Composition for the treatment of psoriasis and eczema, in the form of an ointment or cream, contains fish collagen in the form of gel in the amount of 5 - 80% by volume, jojoba oil in the amount of 1-75% by volume, cetyl alcohol in the amount of 0.5 - 8% by volume, petroleum jelly in an amount of 5 - 25% by volume and an essential oil in an amount of 0 - 5% by volume, preferably orange oil.

PL409095A 2014-08-04 2014-08-04 A composition for the psoriasis and eczema therapy PL225026B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL409095A PL225026B1 (en) 2014-08-04 2014-08-04 A composition for the psoriasis and eczema therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL409095A PL225026B1 (en) 2014-08-04 2014-08-04 A composition for the psoriasis and eczema therapy

Publications (2)

Publication Number Publication Date
PL409095A1 true PL409095A1 (en) 2016-02-15
PL225026B1 PL225026B1 (en) 2017-02-28

Family

ID=51585159

Family Applications (1)

Application Number Title Priority Date Filing Date
PL409095A PL225026B1 (en) 2014-08-04 2014-08-04 A composition for the psoriasis and eczema therapy

Country Status (1)

Country Link
PL (1) PL225026B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL448126A1 (en) * 2024-03-28 2025-09-29 Uniwersytet Mikołaja Kopernika W Toruniu Medical preparation for diseased skin care

Also Published As

Publication number Publication date
PL225026B1 (en) 2017-02-28

Similar Documents

Publication Publication Date Title
CL2020000632A1 (en) Composition and method for the treatment of autism.
CY1120529T1 (en) FUMARS PRODUCTS AND THEIR USE IN EDUCATION OF VARIOUS DISEASES
MX387604B (en) STABLE CANNABINOID FORMULATIONS.
BR112015029969A2 (en) cancer treatment using pi3 isoform kinase modulators
MX2018011348A (en) COMPOSITIONS OF NATURAL EXTRACTS AND USE OF THE SAME TO PREVENT OR TREAT DISEASES.
EA201791299A1 (en) MICROINCAPSULATED COMPOSITIONS OF CANNABINOIDS
MX373306B (en) COMPOSITIONS AND METHODS FOR MODULATING THE EXPRESSION OF APOLIPOPROTEIN C-III.
MX383164B (en) COMPOSITION CONTAINING RNA FOR THE TREATMENT OF TUMOR DISEASES.
MX2017000569A (en) Silicone emulsions.
BR112015023760A2 (en) therapeutic compounds and compositions
MX2015003239A (en) TOPICAL COMPOSITIONS AND METHODS OF USE.
EA201691808A1 (en) CORTICOSTEROID COMPOSITIONS FOR LOCAL APPLICATION
CL2015000608A1 (en) Daptomycin formulations and uses thereof
NZ756307A (en) Formulations of cannabinoids for the treatment of acne
PE20160801A1 (en) HETEROBICICLOARIL DERIVATIVES AS RORC2 INHIBITORS AND METHODS OF USE OF THE SAME
UY34800A (en) PHARMACEUTICAL COMBINATIONS CONTAINING AN INHIBITOR OF 11-BETA-HYDROXIESTEROID DEHYDROGENASE-1 USEFUL IN METABOLIC DISORDERS
NZ702472A (en) Oil/water-emulsion-type topical compositions containing a retinoid
CR20150653A (en) NEW COMPOUNDS FOR CANCER TREATMENT
EA201791814A1 (en) IMIDAZOLYL TRYCYCLIC ENONS AS ANTIOXIDANT INFLAMMATION MODULATORS
CO2019009020A2 (en) Pyrazole derivatives as bromodomain inhibitors.
TR201905218T4 (en) USEFUL VITANOLIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES.
BR112015020066A2 (en) composition in the form of an oil-in-water emulsion, cosmetic process for treating and / or caring for human keratin materials, cosmetic process for treating human sweating and / or perspiration-related body odor and dispensing device
MX343517B (en) 2,4 substituted pyrimidinediamines for use in discoid lupus.
CY1122457T1 (en) NON-VOLATILE OPHTHALMIC COMPOSITIONS, SPECIFIC FOR THE TREATMENT OF DRY EYE
BR112015016391A2 (en) pyrazolyl-based carboxamides i as crac channel inhibitors